Aclarion (ACON) shares closed on Friday 110% higher, after the company said it has cancelled an agreement with Ascendiant Capital to offer $10 million shares through a series of at-the-market offerings.
The magnetic resonance spectroscopy company received about $300,000 in gross proceeds through the offerings during the duration of the agreement that was entered in September 2024, according to a regulatory filing on Friday.